Other medicines, foods and herbal products can change how Pemetrexed works. Everything on this page comes from Pemetrexed's own FDA-approved label — the same source as the main guide.
Grouped the way the label groups them. Each name links to that medicine's NepalDoc guide; where the label names a class instead of a medicine, the label's words are quoted.
Effects of Ibuprofen on Pemetrexed Ibuprofen increases exposure (AUC) of pemetrexed . In patients with creatinine clearance between 45 mL/min and 79 mL/min: Avoid administration of ibuprofen for 2 days before, the day of, and 2 days following administration of PEMRYDI RTU .
Pemetrexed's label names 1 medicines that NepalDoc also covers.
These medicines named in Pemetrexed's label have interaction pages of their own:
Effects of Ibuprofen on Pemetrexed Ibuprofen increases exposure (AUC) of pemetrexed . In patients with creatinine clearance between 45 mL/min and 79 mL/min: Avoid administration of ibuprofen for 2 days before, the day of, and 2 days following administration of PEMRYDI RTU . Monitor patients more frequently for myelosuppression, renal, and gastrointestinal toxicity, if concomitant administration of ibuprofen cannot be avoided. Ibuprofen increased risk of PEMRYDI RTU toxicity in patients with mild to moderate renal impairment. Modify the ibuprofen dosage as recommended for patients with a creatinine clearance between 45 mL/min and 79 mL/min.
Pemetrexed guide · All interaction pages · Medicines A–Z
This page summarises Pemetrexed's FDA-approved label for information — it is not medical advice. Always tell your doctor or pharmacist about every medicine, supplement and herbal product you take.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.